AEMD实时信号 | 通过Getagraph.com最大化利润

Live Chart Being Loaded With Signals

Commentary (18 May 2024 @ 04:00):

Aethlon Medical, Inc., a medical technology company, focuses on developing products to diagnose and treat life and organ threatening diseases in the United States...

Stats
今日成交量	1.06M
平均成交量	561 150
市值	1.05M
EPS	$0 ( 2024-02-14 )
下一个收益日期	( $-1.180 ) 2024-06-26
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.0800
ATR14	$0.00200 (0.48%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-16	Broenniman Edward G	Buy	32 894	Common Stock
2024-04-16	Rossetti Angela	Buy	32 894	Common Stock
2024-04-16	Shah Chetan	Buy	32 894	Common Stock
2024-04-16	Gikakis Nicolas	Buy	32 894	Common Stock
2024-03-29	Gikakis Nicolas	Sell	1 954	Common Stock

INSIDER POWER
77.12
Last 96 transactions
Buy: 2 829 634 \| Sell: 209 502

音量相关性

長: -0.25 (neutral)

短: 0.96 (very strong)

Signal:(45.698) Expect same movement, but be aware

Aethlon Medical Inc 相关性

10 最正相关
HSDT	0.9
MRAM	0.896
LINK	0.893
CETX	0.888
ARAY	0.887
RMNI	0.885
INTC	0.88
XRAY	0.876
CVRX	0.873
III	0.872

10 最负相关
IGTA	-0.904
IESC	-0.904
LSAK	-0.903
REAX	-0.899
PRCT	-0.894
XFIN	-0.887
SGMA	-0.883
MSSA	-0.877
GGAL	-0.877
USLM	-0.873

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Aethlon Medical Inc 相关性 - 货币/商品

0.00
( neutral )

0.33
( neutral )

0.00
( neutral )

-0.13
( neutral )

Aethlon Medical Inc 财务报表

Annual	2023
营收:	$574 245
毛利润:	$-4.44B (-773 707.70 %)
EPS:	$-69.72

FY	2023
营收:	$574 245
毛利润:	$-4.44B (-773 707.70 %)
EPS:	$-69.72

FY	2022
营收:	$294 165
毛利润:	$139 948 (47.57 %)
EPS:	$-7.06

FY	2021
营收:	$659 104
毛利润:	$0.00 (0.00 %)
EPS:	$-0.650

Financial Reports:

No articles found.

Aethlon Medical Inc Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Aethlon Medical Inc

Aethlon Medical, Inc., a medical technology company, focuses on developing products to diagnose and treat life and organ threatening diseases in the United States. The company develops Aethlon Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses from the human circulatory system, including removal of COVID-19 virus, associated variants, and related exosomes. Aethlon Medical, Inc. has a collaboration with the University of Pittsburgh Medical Center Hillman Cancer Center for studies related to head and neck cancer. The company was founded in 1999 and is based in San Diego, California.